Kre1p, the Plasma Membrane Receptor for the Yeast K1 Viral Toxin  by Breinig, Frank et al.
Cell, Vol. 108, 395–405, February 8, 2002, Copyright 2002 by Cell Press
Kre1p, the Plasma Membrane Receptor
for the Yeast K1 Viral Toxin
to study K1 as representative of this group and to com-
pare it with K28, which has a different primary receptor
and a unique mode of action.
Frank Breinig,1 Donald J. Tipper,2
and Manfred J. Schmitt1,3
1Angewandte Molekularbiologie
The primary gene products of the M1- and M28-Universita¨t des Saarlandes
dsRNA genomes, though lacking sequence homology,D-66041 Saarbru¨cken
share a very similar organization and pattern of pro-Germany
cessing, closely resembling that of insulin. Both prepro-2 Department of Molecular Genetics
toxins consist of an N-terminal leader peptide precedingand Microbiology
the relatively hydrophobic toxin -subunit, which isUniversity of Massachusetts Medical School
separated from the more hydrophilic -subunit by anWorcester, Massachusetts 01655
intervening N-glycosylated -sequence. The secreted
protoxin, produced by removal of the leader peptide, is
processed within the yeast secretory pathway by theSummary
Kex2p protease, which trims the  N terminus and re-
moves . The Kex1p carboxypeptidase subsequentlySaccharomyces cerevisiae K1 killer strains are in-
trims the  C terminus and, in K28, also trims the fected by the M1 double-stranded RNA virus encod-
C terminus. A mature, heterodimeric toxin is produceding a secreted protein toxin that kills sensitive cells
whose - and -subunits are covalently linked by oneby disrupting cytoplasmic membrane function. Toxin
or more disulfide bonds and which is released into thebinding to spheroplasts is mediated by Kre1p, a cell
culture medium (Schmitt and Tipper, 1995; Bostian etwall protein initially attached to the plasma membrane
al., 1984; Wickner and Leibowitz, 1976).by its C-terminal GPI anchor. Kre1p binds toxin di-
Both K1 and K28 toxins kill sensitive yeast cells in arectly. Both cells and spheroplasts of kre1 mutants
receptor-mediated multistage process (Al-Aidroos andare completely toxin resistant; binding to cell walls
Bussey, 1978). The first step involves a rapid and energy-and spheroplasts is reduced to 10% and 0.5%, re-
independent binding to a primary receptor in the yeastspectively. Expression of K28-Kre1p, an inactive C-ter-
cell wall. K1 toxin is then transferred to the plasma mem-minal fragment of Kre1p retaining its toxin affinity and
brane, where it exerts its energy-dependent lethal ef-membrane anchor, fully restored toxin binding and
fects, disrupting membrane function by forming cationsensitivity to spheroplasts, while intact cells remained
specific ion channels (de la Pen˜a et al., 1981). The K1resistant. Kre1p is apparently the toxin membrane re-
receptor is the -1,6-glucan fraction of the cell wall,ceptor required for subsequent lethal ion channel for-
while the K28 receptor is a high molecular weight man-mation.
noprotein fraction (Hutchins and Bussey, 1983; Schmitt
and Radler, 1990). Resistance to K1 toxin was usedIntroduction
to select mutations in several chromosomal KRE (killer
resistant) genes. Although the particular functions of theKiller phenomena are wide-spread in yeast and are
gene products are unknown, these mutations all reducebased on the secretion of protein toxins (killer toxins)
cell wall -1,6-D-glucan content and cause resistancelethal to sensitive strains of the same species and a
to K1 toxin in whole cells as a consequence of decreasedvariable spectrum of other yeast genera (Young and
cell wall affinity (for reviews, see Boone et al., 1990;Yagiu, 1978). Killer strains are specifically immune to
Brown et al, 1993; Shahinian and Bussey, 2000). Sphero-
their own toxins but remain sensitive to those of other
plasts are more sensitive to killer toxins than are whole
killer types. S. cerevisiae killer toxins are encoded by
cells, and spheroplasts of all described kre mutants
linear, double-stranded M-dsRNA viruses that replicate retain normal toxin sensitivity. Thus, binding to the cell
stably within the cytoplasm of the infected host cell as wall glucan is presumed to be required for access to
satellites of the L-A dsRNA virus. Since uninfected wild- the plasma membrane target. The resistance in whole
type strains are sensitive, killer viruses self-select by cells conferred by these kre mutations is saturable, con-
killing any virus-free segregants. Three distinct killer vi- sistent with significant residual cell wall affinity for K1
ruses (ScV, for S. cerevisiae virus) have been well char- toxin in these mutants; presumably, higher toxin con-
acterized: ScV-M1, ScV-M2, and ScV-M28. These centrations can still reach the membrane target. In con-
viruses contain the M1-, M2-, and M28-dsRNAs, respec- trast, immunity confers resistance to all levels of toxin
tively, and analysis of cDNAs shows that each contains in both whole cells and spheroplasts. Because of these
a single open reading frame encoding both the precursor observations, the existence of a specific and essential
of the secreted K1, K2, or K28 killer toxin and specific secondary plasma membrane toxin receptor was postu-
immunity to that toxin (for reviews, see Schmitt and lated; immunity was proposed to result from loss of this
Eisfeld, 1999; Wickner, 1996; Wickner et al., 1995; Tipper receptor in killer cells due to its interaction with protoxin
and Schmitt, 1991). Because the K1 and K2 killer toxins during secretion, leading to diversion to the vacuole
share primary cell wall receptors and have a mode of (Sturley et al., 1986; Tipper and Schmitt, 1991).
action common to most killer toxins, we have chosen Channel formation by K1 toxin in yeast membranes
was reported in vitro using patch-clamping techniques
(Martinac et al., 1990), apparently resulting from direct,3 Correspondence: mjs@microbiol.uni-sb.de
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receptor-independent toxin action. This observation, resistant and gave rise, on sporulation, to four resistant
haploid segregants (data not shown). To obtain addi-however, is inconsistent with complete resistance in
immune spheroplasts, and no such receptor-indepen- tional confirmation, we transformed SEY6210 [kre1],
the corresponding wild-type sensitive strain SEY6210,dent channels were observed in a more recent study in
which it was demonstrated that K1 toxin activates Tok1p the kre12 point mutants R95/8b and R95/8d, and their
sensitive parental strains 506 and 518 with a wild-typepotassium channels in yeast membranes and when
these channels are expressed in Xenopus oocytes copy of KRE1 cloned into the multicopy plasmid YEp351.
A standard dose of 103 units of K1 toxin, used in the(Ahmed et al., 1999). These channels were postulated
to be responsible for lethal interaction of toxin with the quantitative well test for toxin sensitivity, produced col-
ony-free killing zones of 14–15 mm on lawns seededplasma membrane and to be a potential toxin receptor.
More recently, it was demonstrated that exposure of with the sensitive strains SEY6210, 506, and 518, but
no zone on SEY6210 [kre1] or the kre12 mutant strains.these channels to toxin from the cytoplasmic face pre-
vents activation from the external face, and this was Transformation with KRE1 restored normal sensitivity
(zones of 14–15 mm) in all three mutants (not shown).postulated to be the mechanism of immunity (Sesti et
al., 2001). We now show that these channels are neither The isolated YCp50[KRE12] clones also complemented
toxin resistance in strain SEY6210 [kre1]. The originalthe membrane receptor nor the primary toxin target, nor
are they responsible for immunity. kre12 mutation, therefore, was renamed kre1-12. Clon-
ing and sequencing of the kre1-12 allele revealed thatIn a search for the postulated K1 membrane receptor,
we selected for resistance in spheroplasts. Multiple mu- it harbors a nonsense mutation in KRE1 leading to termi-
nation at codon 85 (CAG to TAG). A kre1-12 mutant,tants in a single recessive complementation group
called kre12 were isolated, and kre12 mutants were therefore, secretes a truncated Kre1p lacking the
C-terminal 229 amino acids, including the C-terminalshown to be defective for toxin binding to the plasma
membrane (Schmitt and Compain, 1995). Here we ex- signal apparently responsible for addition of a GPI an-
chor in the endoplasmic reticulum (Roemer and Bussey,tend these findings by demonstrating that kre12 mutants
are alleles of KRE1. The gene product, Kre1p, is there- 1995).
fore involved in K1 toxin action at multiple levels. Ma-
ture Kre1p is a secreted, glycosyl-phosphatidylinositol- Deletion of KRE1 Reduces Binding of K1 Toxin
(GPI)-linked glycoprotein of about 265 residues. It was to the Cell Wall and Eliminates Binding
previously shown that the resistance to K1 toxin in whole to the Plasma Membrane
cells of kre1 mutants results from a 40% reduction in Both intact cells and spheroplasts of kre1 null and
-1,6-glucan content and a distinct reduction in affinity kre1-12 mutants were completely resistant to K1 toxin
of cell walls for toxin, although spheroplasts of pre- in the well assay at a concentration 10 times the 103 units
sumed null alleles retained normal toxin sensitivity used in the standard assay for sensitivity (not shown).
(Boone et al., 1990). We now show that both cells and Spheroplast resistance was unexpected since all pre-
spheroplasts of deletion mutants (kre1) are completely viously tested kre1 alleles, including those completely
resistant. Moreover, while expression of wild-type Kre1p defective for their unidentified function in -1,6-glucan
restored sensitivity to both whole cells and sphero- synthesis, had sensitive spheroplasts (Boone et al.,
plasts, a secreted, GPI-anchored, enzymatically inactive 1990). We therefore investigated K1 toxin binding to
C-terminal fragment of Kre1p of about 63 residues re- whole cells and spheroplasts in the kre1 null mutant.
stored K1 toxin binding and sensitivity only to sphero- We had previously reported that cells of kre1-12 mutants
plasts. We therefore postulate that the GPI-linked have near normal toxin affinity while their spheroplasts
C terminus of Kre1p is the essential membrane receptor have markedly reduced affinity (toxin affinity in wild-
for K1 toxin and present a refined model for K1 toxin type spheroplasts is only about 5% of that in intact cells,
action. but is nevertheless reproducible) (Schmitt and Compain,
1995). Strain SEY6210 [kre1] behaves similarly; whole
cells bound about 10% of the toxin bound by isogenicResults
KRE1 cells (Figure 1A) while spheroplasts bound only
about 0.5% of normal levels (Figure 1B), so that toxinKRE12 Is Allelic to KRE1
binding was only detectable when spheroplast concen-We isolated the KRE12 gene by functional complemen-
trations were more than 100-fold higher than those attation. The kre12 mutant R95/8d was transformed with a
which the wild-type strain binds toxin efficiently.yeast genomic library cloned into the centromeric vector
YCp50 (Rose et al., 1987). Uracil prototrophs were
screened for sensitivity to K1 toxin (Kre phenotype). 3 Construction of Vectors for High Level Expression
of Kre1p and of K28-Kre1p, an 88 Residueout of 12,000 independent transformants showed K1
sensitivity comparable to the KRE12 wild-type. In each C-terminal Fragment of Kre1p
KRE1 encodes Kre1p, a 313 residue serine/threonine-case, sequencing of the genomic insert fragment in the
complementing plasmids (designated YCp50[KRE12]) rich secreted protein involved in late stages of synthesis
and/or assembly of yeast cell wall -1,6-D-glucansidentified a single intact open reading frame that corre-
sponded to KRE1. To confirm the allelism of kre12 and (Boone et al., 1990). The mature protein is apparently
extensively O-glycosylated and is associated with bothKRE1, we crossed several kre12 mutant segregants to
the K1-resistant mutant SEY6210 [kre1], in which the the plasma membrane and the cell wall. Boone et al.
(1990) replaced the 59 carboxyterminal amino acids ofentire Kre1p open reading frame is replaced by the HIS3
gene. All diploids derived from these crosses were toxin Kre1p, including the hydrophobic membrane anchor re-
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Figure 2. Construction of Kre1p Receptor Fusions
Schematic drawing of full-length Kre1p (A), the K28-Kre1p fusion
(B) and its GFP fusion K28-GFP-Kre1p (C). In K28-Kre1p, residues
1–225 of wild-type Kre1p, including the Ser-Thr rich region (residues
60–175), were replaced by residues 1–79 of the K28 preprotoxin
encoding its 31 residue N-terminal leader peptide, a Kex2p pro-
cessing site after residue 49, and the first 29 residues of the mature
toxin’s -subunit. SP, signal peptidase cleavage site; HD, C-terminal
hydrophobic domain of Kre1p replaced by a GPI anchor in the ER;
Kex2p, endopeptidase processing site within the toxin’s -subunit;
amino acid length of each fusion protein is indicated.
K1, we constructed multicopy YEp vectors expressing,
from the efficient PGK promoter, either Kre1p (Figure
2A) or a fusion (K28-Kre1p) in which the N-terminal 225
residues of Kre1p are replaced by an N-terminal frag-
ment of the K28 preprotoxin (Figure 2B). This fragment
is included because of its efficient secretion signal. Fol-
Figure 1. KRE1 Deletion Dramatically Decreases K1 Toxin Binding lowing secretion and processing at residue 49 within
to the Yeast Cell Surface
the K28 precursor fragment by the luminal Kex2p prote-
Binding of K1 toxin to intact cells (A) and spheroplasts (B) of KRE1
ase, the product should consist of the first 29 residuesand kre1 derivatives of S. cerevisiae strain SEY6210. Spheroplasts
of the -subunit of K28 toxin fused to the C-terminal 88typically bind about 5% as much toxin as an equal number of intact
residues of Kre1p, including the C-terminal 25 residuecells. Intact cells and spheroplasts at the indicated concentrations
were incubated in 1 ml of 100 mM McIlvaine buffer (pH 4.7) for 10 signal for GPI addition. Replacement by a GPI anchor
min at4C in the presence of 104 units K1 toxin. Cells were pelleted in the ER is predicted to leave 63 C-terminal residues,
by centrifugation and toxin activity remaining in the supernatant was 23% of mature Kre1p, in an 11 kDa fusion peptide.
assayed by the well test (standard deviation from three independent
experiments was 10%).
The C-Terminal 88 Amino Acids of Kre1p
Are Sufficient to Target K28-Kre1p
to the Yeast Plasma Membranegion, with a substance P epitope and showed that the
fusion protein (Kre1p-SP) was secreted into the medium. and Cell Wall
Yeast has two major classes of GPI-linked proteins.They also demonstrated that a fusion of an N-terminal
fragment of Kre1p to the mature sequence of Pho5p Those such as Gas1p, with a dibasic moiety immediately
preceding the GPI addition site, retain their anchor andresulted in secretion of active Pho5p, acid phosphatase.
The Kre1p N terminus, therefore, is an efficient secretion remain associated with the plasma membrane. Those
such as the -agglutinin, that lack this moiety, becomesignal. Although neither the N nor C termini of the mature
protein have been determined, processing of Kre1p dur- attached to the cell wall by a transglycosylation event
that transfers the mannose residues of the GPI anchoring secretion presumably involves removal of the 23
residue N-terminal hydrophobic leader sequence and from the lipid to the -1,6-glucan; certain residues at
the 2 and 5 positions promote efficient transfer (Ha-replacement of the 25 residue C-terminal hydrophobic
region by a GPI anchor (Roemer and Bussey, 1995; Ha- mada et al., 1999). Kre1p lacks either signal, and both
Kre1p and the K28-Kre1p fragment are expected to bemada et al., 1998). This is supported by analysis of an
N-terminal deletion derivative. transferred at lower efficiency to the glucan. This would
explain why about 70% of Kre1p is associated with theTo test the role of Kre1p as the membrane receptor for
Cell
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Figure 3. Cell Surface Localization of the K1
Toxin Receptor Kre1p
(A) Laser scanning fluorescence microscopy
of kre1 mutant cells expressing K28/GFP/
Kre1p.
(B) Western analysis of the SEY6210 [kre1]
mutant transformed with pPGK-[K28-Kre1p]
expressing the K28-Kre1p fusion. The arrow
indicates the 12.5 kDa K28-Kre1p fusion
protein.
(C) Western analysis of subcellular fractions
of yeast kre1 mutant cells expressing K28/
GFP/Kre1p. Yeast cells were spheroplasted
and the supernatant (the soluble cell wall
fraction) was dialyzed and lyophilized. Mem-
branes were isolated from the disrupted
spheroplasts, and cell wall and membrane
fractions were fractionated by SDS-PAGE
and detected using a monoclonal anti-GFP
antibody as probe and a secondary mouse
anti-IgG antibody. Positions of the Zymoly-
ase-extractable fusion protein [K28/GFP/
Kre1p] and its presumed GPI-anchored pre-
cursor [K28/GFP/Kre1p (GPI?)] are indicated.
cell wall and 30% with the membrane (Roemer and Bus- solubilized by treatment with the-1,3-glucanase Zymo-
lyase-20T. This component had the 38 kDa size pre-sey, 1995).
Because the K28-Kre1p fusion contains epitopes de- dicted for the product of release of the fusion protein
by cleavage of the GPI anchor (Figure 3C). Most of thetectable with polyclonal antiserum raised against the
K28 /-peptide (Eisfeld et al., 2000), we were able to rest cofractionated with the remaining plasma mem-
brane fraction as a species whose apparent size wasdetermine its location by Western blot analysis. As
shown in Figure 3B, K28-Kre1p was detected in lysates 48 kDa, consistent with retention of a GPI anchor (Figure
3C). This lane corresponds to considerably more cellsof mechanically broken cells with an apparent molecular
weight of 12.5 kDa, slightly larger than predicted for the than shown for the cell wall-associated fraction. Based
on staining intensity, we estimate that these fractionscorrectly processed fusion protein. A minor fraction of
K28-Kre1p was secreted into the culture medium (Figure contained roughly equal amounts of the K28/GFP/Kre1p
fusion. We therefore conclude that the fusion protein3B), in contrast to the K28 toxin fragment lacking the
attached Kre1p C-terminal fragment, which was effi- and, by implication, Kre1p itself, has two components:
one GPI-linked to the plasma membrane and the otherciently secreted into the medium (not shown). No signal
was detected in the untransformed control (not shown). covalently linked to the cell wall glucan, as previously
predicted (Roemer and Bussey, 1995; Hamada et al.,To further confirm the cellular localization of K28-
Kre1p, we constructed a fusion in which the green fluo- 1999). Furthermore, all of the Kre1p localization signals,
for both membrane insertion and transfer to the wall,rescent protein GFP was cloned in frame at the BamHI
site linking the N-terminal fragment of K28 preprotoxin are contained within its C-terminal 88 residues.
and the C-terminal fragment of Kre1p (Figure 2C). Laser
scanning fluorescence microscopy revealed that the re- The C-Terminal Kre1p Fragment Restores K1
Toxin Binding and Sensitivity of a kre1 Nullsulting K28/GFP/Kre1p fusion, expressed in a kre1 null
mutant, was localized to the cell surface, as expected Mutant, but Only in Spheroplasts
Because our data suggested that the GPI-linked form(Figure 3A). Moreover, Western blot analysis using com-
mercial antiserum to GFP for detection showed that of Kre1p might be the membrane receptor for K1 toxin,
we investigated the effect of expression of K28-Kre1pa major component of this fusion protein remained
attached to cell walls washed with 2% SDS but was on sensitivity to K1 toxin. The SEY6210 [kre1] null mu-
Membrane Receptor for the Yeast K1 Viral Toxin
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strain raised toxin binding in whole cells to the level
seen in Kre1 wild-type cells (Figure 1A) as expected,
since normal sensitivity is also restored. -1,6 glucan
content, 54 	g/mg cell wall dry weight in the kre1
strain, was restored to 91 	g/mg, slightly above the
normal level (84 	g/mg), consistent with normal Kre1p
function, toxin binding affinity, and sensitivity. In con-
trast, expression of the K28-Kre1p fusion failed to in-
crease toxin binding to whole cells; binding remained
at about 10% of the level seen in the complemented
strain (Figure 1A). As expected, wall -1,6 glucan con-
tent remained unchanged at 54 	g/mg, consistent with
the predicted lack of enzymatic function in the C-ter-
minal Kre1p fragment present in this fusion and the
continued resistance of cells of these transformants to
K1 toxin. The glucan content of SEY6210 [KRE1] cells
was also unaffected by expression of K28-Kre1p. How-
ever, as shown in Figure 1B, expression of both Kre1p
and the K28-Kre1p fusion restored wild-type levels of
K1 toxin binding to spheroplasts, consistent with the
observed wild-type sensitivity (Figures 4C and 4D).
Again, presumed overexpression of neither the full
length nor the truncated Kre1p increased toxin binding
to or sensitivity of spheroplasts beyond the normal level.
Based on these results, we postulate that the C-terminal
63 residues of Kre1p, when GPI-linked to the plasma
membrane, comprise the plasma membrane binding site
of K1 killer toxin required for lethality. Transfer of this
fusion fragment to the cell wall, however, does not affect
the binding of toxin to the wall.Figure 4. Expression of K28-Kre1p Restores K1 Sensitivity to kre1
Null Mutant Spheroplasts
105 spheroplasts of the indicated yeast strain were seeded on MBA Kre1p Binds to K1 Toxin Immobilized
plates (pH 4.7; 1.2 M sorbitol), and 104 units of K1 toxin were added on a Pustulan Matrix
to wells cut into the plates. Plates were photographed after 5 days Pustulan, a soluble linear -1,6 glucan, is an analog of
at 20C. (A) SEY6210; (B) SEY6210 [kre1]; (C) SEY6210 [kre1]  the yeast cell wall receptor for K1 toxin. It was previously
pPGK-[Kre1p]; (D) SEY6210 [kre1]  pPGK-[K28-Kre1p].
demonstrated that toxin bound to a column of immobi-
lized pustulan could be eluted in active form using a
gradient of increasing NaCl concentration (Hutchins andtant and the wild-type parent SEY6210 were trans-
formed with either pPGK-[Kre1p] or pPGK-[K28-Kre1p]. Bussey, 1983). In order to demonstrate direct binding
of Kre1p to toxin, therefore, we bound 1 ng of K1 toxinResults of tests for K1 sensitivity in the well plate assay
are shown in Figure 4. Expression of full length Kre1p (104 units) to a column of a pustulan-sepharose matrix
and used this column to bind, in turn, about 2 ng ofrestored normal sensitivity to both whole cells and sphe-
roplasts of the kre1 null mutant of strain SEY6210. Kre1p. The Kre1p preparation had an N-terminal T7 epi-
tope tag preceding the normal secretion signal, allowingUsing 104 units of toxin in the well assay, identical zone
sizes (16 mm) were produced on lawns of both the detection on Western blots, and was derived directly
from a lysate of E. coli cells expressing the T7-Kre1pSEY6210 sensitive parental strain and the comple-
mented mutant (not shown). Similarly, complete re- fusion. Fractions eluted from the column with a linear
NaCl concentration gradient were assayed by Westernsistance seen in the mutant spheroplasts (Figure 4B)
reverted to normal sensitivity in the presence of pPGK- blot using anti-T7 serum for the T7-Kre1p fusion and by
the well assay for toxin activity.[Kre1p] (compare Figures 4A and 4C). However, while
expression of the truncated K28-Kre1p fragment failed As shown in Figure 5A, all toxin activity eluted in frac-
tions 10–11 corresponding to 0.4–0.5 M NaCl. The zoneto restore detectable sensitivity to intact cells (not
shown), sensitivity in spheroplasts was fully restored size corresponded to full recovery of the 1 ng of toxin
originally bound to the column. These same combined(Figure 4D). Interestingly, overexpression of neither full-
length Kre1p nor K28-Kre1p from these YEp vectors in fractions also contained all of the eluted T7-Kre1p (Fig-
ure 5B, lane 4). The band in this lane was derived fromthe Kre1 wild-type significantly affected K1 sensitivity
in either whole cells or spheroplasts, suggesting that the pooled eluates from six column runs. The signal was
close to that observed for 10 ng of T7-Kre1p in theeither the amount of GPI-linked Kre1p at the plasma
membrane surface cannot be increased or that this is control lane 3. The combined eluates from 6 column
runs lacking bound toxin are shown in lane 5. The pustu-not rate limiting for the lethal action of K1 toxin. Expres-
sion of these constructs also failed to affect immunity lan matrix alone, in the presence of concentrated culture
supernatant from a nonkiller strain, or in the presencein a killer strain (not shown).
Expression of full-length Kre1p in the SEY6210 [kre1] of 1 ng of K1 toxin inactivated by mild heat treatment
Cell
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Figure 5. Binding and coelution of K1 toxin and T7-Kre1p or K28-Kre1p from a pustulan-sepharose affinity matrix.
(A) K1 toxin (1 ng) was bound to a column of pustulan-sepharose and used to bind 2 ng of T7-Kre1p present in an E. coli lysate in 10 mM
McIlvaine buffer (pH 4.7). Bound toxin was eluted using a linear NaCl gradient (0–500 mM) in the same buffer. Fractions were assayed for
toxin activity. Only fractions 10–11, as shown, contained significant activity.
(B) The same fractions, pooled from 6 column runs, were ethanol-precipitated and analyzed by Western blot probed with a monoclonal anti-
T7 serum. Lane 1, a control of 12 ng of untagged K1 toxin; lane 2, a T7-tagged recombinant protein of 31 kDa supplied by the manufacturer;
lane 3, E. coli lysate containing 10 ng of T7-Kre1p; lane 4, the pooled eluates; lane 5, pooled eluates from six columns lacking bound toxin.
(C) K1 toxin (4 ng) was bound to a column of pustulan-sepharose and used to bind 5 ng of K28-Kre1p present in 10 mM McIlvaine buffer (pH
4.7). Bound toxin was eluted as in (A). Fractions 10–11, containing all of the eluted K1 toxin activity, were pooled from 6 column runs, ethanol-
precipitated, and analyzed by Western blot probed with a polyclonal antibody against the K28  moiety (Eisfeld et al., 2000). Lane 6, the
pooled eluates; lane 7, pooled eluates from six columns lacking bound toxin.
failed to bind detectable quantities of T7-Kre1p. We are activated by K1 toxin in membrane patches from
either yeast cells or Xenopus oocytes expressing theseconclude, therefore, that approximately 2 ng of T7-
Kre1p binds per ng of bound toxin, indicating approxi- channels and suggested that they are important lethal
targets for K1 toxin, independent of any additional re-mate stoichiometry, since the molecular weights are
33.5 and 18.5 kDa, respectively. ceptor. Their hypothesis was supported by an assay
Using the same procedure, we also demonstrated that that showed a modest decrease in toxin sensitivity in
retention of K28-Kre1p on a pustulan column was de- tok1 mutants grown in mixed culture with a killer strain.
pendent on the presence of prebound active K1 toxin However, the efficiency of killing under these conditions
(Figure 5C). The fraction eluted at about 0.5 M NaCl is low because of the modest concentrations of secreted
containing all of the active toxin also contained the active toxin present, and the assay is consequently im-
eluted K28-Kre1p (12.5 kDa), detected by Western blot precise. Moreover, since we observe very high resis-
using antiserum to the K28  toxin moiety (Figure 5C, tance in spheroplasts of kre1 mutants and Tok1p is
lane 6). No binding occurred in the absence of toxin presumably still present in these membranes, it seems
(lane 7). unlikely that Tok1p is an important direct target of K1
toxin action. We therefore used the far more accurate
and reproducible well test to compare toxin sensitivityDeletion of TOK1 Encoding the Tok1p K
in a tok1 mutant and its TOK1 parent. We were unableChannels Affects Neither K1 Toxin
to detect any difference (Figure 6A). In a more recentSensitivity Nor Immunity
paper, Sesti et al. have demonstrated that exposure ofThe mechanism of toxin immunity remains unknown.
membrane patches containing Tok1p channel to K1The high toxin sensitivity in spheroplasts from sensitive
toxin on their cytoplasmic face prevents activation bycells and the complete resistance seen in immune sphe-
toxin on their external face (2001). Based on the assump-roplasts implies the existence of a membrane receptor
tion that these channels are a major lethal target, theythat is either masked, mislocalised, or destroyed in im-
suggested that immunity results from cytoplasmic inter-mune cells (Sturley et al., 1986). Kre1p appears to be
action of toxin in killer cells with this channel. Althoughthe primary membrane receptor, but is neither the lethal
activation of Tok1p channels may be prevented by thistarget nor the target of the immunity mechanism, im-
mechanism, neither toxin secretion nor immunity wasplying the existence of a downstream membrane com-
detectably affected by atok1 mutation in cells express-ponent that fulfills these functions (see Discussion).
ing the K1 preprotoxin gene from a cDNA plasmid copyAhmed et al. (1999) showed that the plasma membrane
Tok1p potassium-selective ion channels of S. cerevisiae (Figures 6B and 6C).
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in S. cerevisiae remains the most intriguing unresolved
aspect of the killer phenomenon. While our results do
not solve it, they bring it into sharper focus.
The toxins must bind to the cell wall of intact cells
with high affinity in order to reach the plasma membrane
where they exert their lethal effects or, in the case of
K28, are endocytosed (Schmitt and Eisfeld, 1999; Eisfeld
et al., 2000). All previously well characterized chromo-
somal resistant (kre) mutants cause loss of cell wall
affinity for K1 toxin without affecting sensitivity in sphe-
roplasts. In contrast, immune cells retain normal cell
wall affinity for toxin, implying normal KRE gene product
function, but both cells and spheroplasts are completely
resistant. It was natural, therefore, to propose that lethal-
ity requires a secondary toxin receptor at the plasma
membrane and that its loss or modification causes im-
munity. When we first demonstrated that expression of
a cDNA copy of the preprotoxin was sufficient to confer
normal immunity, we postulated that the central  com-
ponent of this precursor provided a masking function
as both membrane receptor and protoxin passed
through the secretory pathway (Bostian et al., 1984). We
later proposed a more plausible model, interaction of
secreted protoxin with the receptor, through the same
toxin domain involved in lethality, resulting in diversion
of the complex to the vacuole and destruction (Sturley
et al., 1986). This model was strengthened by mutagenic
analyses indicating that the  toxin segment was the
lethal component and that its secretion in mature form
caused severe growth inhibition, while secretion fused
to just a fragment of  was sufficient for immunity (Zhu
et al., 1993). Dependence of immunity on diversion of the
putative membrane receptor to the vacuole is consistent
with the defect in immunity observed in many vps mu-
tants (D.J.T. et al., unpublished data). One class of kre
mutants, therefore, should show similar resistance in
spheroplasts. In fact, Al-Aidroos and Bussey (1978) de-
scribed a kre3 mutation which caused K1 resistance
without affecting cell wall affinity. Unfortunately, this
mutant has been lost, and we set out to select additional
mutants with resistant spheroplasts, hoping to identify
the membrane receptor.
Figure 6. Neither K1 sensitivity nor K1 immunity are affected in yeast We earlier reported the isolation of kre12 mutants
mutants defective in the Tok1p potassium ion channel. resistant to K1 toxin in both cells and spheroplasts.
(A) MBA agar plates (pH 4.7) were seeded with 105 cells of the TOK1 These mutants showed a marked reduction in toxin
wild-type strain or the isogenic tok1 null mutant. 104 units of K1 binding to the plasma membrane (Schmitt and Compain,
toxin were pipetted into the wells and the plates were incubated at
1995), now shown to exceed 99%. kre12 is now shown20C for 3 days. Note that methylene blue-stained dead cells pro-
to be an allele of KRE1 and is renamed kre1-12. It hasduce the prominent dark ring surrounding the zone of complete
a stop codon at residue 85 and is predicted to secretegrowth inhibition.
(B) For analyzing K1 immunity, strain NY1489 (TOK1) and the iso- a 61 residue N-terminal fragment of the 265 residue
genic NYTOK1 tok1 null mutant were transformed with the K1 mature Kre1p. We also show that kre1 null mutants
preprotoxin expression vector pDT11A (Sturley et al., 1986) and share the spheroplast resistance and almost complete
subsequently tested for sensitivity to 104 units of K1 toxin, as de- loss of toxin binding to spheroplasts seen in the kre1-
scribed in (A).
12 mutant, and that both are fully complemented by(C) To test for K1 toxin secretion, cells of the same transformants
expression of KRE1 from either centromeric or multi-were patched onto MBA plates that had been seeded with 105 cells
copy episomal plasmids. Since no previously describedof the sensitive indicator strain S. cerevisiae 192.2d. Plates were
incubated at 20C for 72 hr. Toxin secretion is indicated by a cell- allele of KRE1 affected spheroplast sensitivity, including
free halo in the lawn of the indicator strain. those apparently lacking all function in -1,6-D-glucan
synthesis, it seemed probable that the critical difference
between the null allele and kre1-12 is not absence of
Discussion function but lack of a GPI-linked form of the protein
which could act as an essential plasma membrane re-
The mechanisms of specific immunity to their own toxins ceptor for K1 toxin.
To test this we constructed K28-Kre1p, a fusion ofconferred by expression of K1, K2, and K28 preprotoxins
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Figure 7. The GPI-anchored cell surface protein Kre1p and its proposed function in K1 toxicity.
Data from de la Pen˜a et al. (1981) and Ahmed et al. (1999) have been incorporated into this model. Toxin action is initiated by binding to the
cell wall glucan which concentrates toxin and promotes transfer to the GPI-linked Kre1p at the plasma membrane. Binding to that receptor
is required for the subsequent and undefined energy-dependent events leading to disruption of transmembrane ion gradients. These events
may include but do not require activation of Tok1 channels.
the C-terminal 88 residues of Kre1p to a fragment of mimicked by binding to pustulan, a homomeric polymer
of -1,6-D-glucan (Hutchins and Bussey, 1983), and itsK28 preprotoxin which provides a secretion signal. Pro-
cessing should produce a 29 residue fragment of the GPI-linked C terminus is the formerly postulated recep-
tor required for subsequent binding to and lethal interac-K28  toxin component fused to a GPI-linked 63 residue
fragment of Kre1p. Analysis of a GFP fusion confirmed tion with the plasma membrane. It is not unusual for a
GPI-anchored protein to act as a toxin receptor; thesurface location of the product and the GPI linkage and
demonstrated transfer to the glucan, as predicted for channel-forming toxins of Aeromonas spp. (Aerolysin)
and Clostridium septicum ( toxin) both bind to GPI-Kre1p (Hamada et al., 1998). An HA-tagged version of
Kre1p was previously shown to be linked to the cell anchored glycoproteins on the plasma membranes of
their corresponding target cells (Gordon et al., 1999;wall (Roemer and Bussey, 1995). Secretion of a minor
fraction of the K28-Kre1p fusion probably resulted from Nelson et al., 1997).
Immune cells and spheroplasts have normal bindingsaturation of the machinery for transfer to the glucan
due to expression from the strong constitutive PGK pro- affinity for K1 toxin (P. Compain, K. Schleinkofer, and
M.J.S., unpublished data), implying normal levels of GPI-moter. Expression of K28-Kre1p in a kre1 null mutant
had no effect on the resistance of whole cells to K1 linked Kre1p membrane receptor and Kre1p function in
glucan synthesis. Immunity, therefore, does not resulttoxin, the -1,6 glucan content of cell walls, or their
affinity for toxin, demonstrating the predicted lack of from loss of the membrane receptor, as predicted by
our original hypothesis (Sturley et al., 1986), but mustKre1p function. However, the fusion protein still bound
toxin, and both toxin binding and sensitivity of sphero- affect some step downstream of binding to Kre1p. As
illustrated in Figure 7, action of K1 toxin is initiated byplasts was fully restored to wild-type levels. Toxin bind-
ing by spheroplasts, therefore, does not require Kre1p binding to the cell wall glucan which concentrates toxin,
promoting transfer to the GPI-linked Kre1p secondaryfunction in glucan synthesis, so cannot be due to Kre1p-
modified nascent membrane-associated glucan. Kre1p, receptor at the plasma membrane. Binding to that re-
ceptor is required for subsequent energy-dependenttherefore, appears to play two roles in sensitivity to K1
toxin. Its function in synthesis of the -1,6-glucan is toxin interaction with undefined primary effectors lead-
ing to disruption of transmembrane ion gradients. Unlikerequired for high affinity binding of toxin to the cell wall,
Membrane Receptor for the Yeast K1 Viral Toxin
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Escherichia coli Strains, Plasmids, and DNA Manipulationsimmune spheroplasts, kre1-12 spheroplasts are still
Standard molecular manipulations were performed as described bykilled by very high K1 toxin concentrations (Schmitt and
Sambrook et al. (1989). E. coli strain DH5 (F recA1 endA1 gyr A96Compain, 1995), potentially reflecting the receptor-inde-
thi hsdR17 supE44 relA1 (argF-lac-ZYA) U169 (φ80dlacZM15) 
)
pendent formation of channels in membrane patches was used for cloning. Plasmid YCp50[KRE1] was isolated from a
reported by Martinac et al. (1990), but more likely due to chromosomal DNA library (Rose et al., 1987). YEp351[KRE1] was
constructed by insertion of the 3.9 kb BamHI/PstI fragment of YCp50Kre1p-independent access to the unidentified primary
[KRE1], encompassing the KRE1 gene and its promoter, into theeffectors (Figure 7). Immunity presumably prevents this
polylinker of the yeast LEU2 2	-based episomal vector YEp351 (Hillstep or its lethal consequences.
et al., 1986). pPGK-M28-I is based on the similar URA3 YEp352The Tok1p channels appear to be a toxin target, but
vector (Hill et al., 1986) and contains the complete K28 preprotoxin
are neither important nor essential to toxin action, since gene under transcriptional control of the constitutive PGK promoter
we detect no difference in sensitivity between a tok1- (Schmitt and Tipper, 1995). KRE1 and its C-terminal 225kre1 frag-
ment were amplified by PCR using YCp50[KRE1] as templatenull mutant and its parent, and Tok1p is presumably still
and the following primer pairs: 5-KRE1 (5-GGG CTC GAG ATGpresent in kre1 mutants whose cells and spheroplasts
ATG CGT CGC ACG CTA-3) and 3-KRE1 (5-GGG AGA TCT TATare almost completely resistant. In addition, de la Pen˜a
AAG AAC CAA ATT AAA AC-3) for KRE1; 5-trKRE1 (5-GGG GATet al. (1981) showed that K1 toxin significantly reduces
CCC AAC GTC CAT GTG GGT C-3) and 3-KRE1 for 225kre1.the pH transmembrane proton gradient at a very early pPGK[KRE1] was constructed by replacing the XhoI/BglII fragment
stage of toxin treatment, well before viability or potas- precisely encompassing the 1.1 kb K28 ORF of pPGK-M28-I with
the XhoI/BglII KRE1 fragment. pPGK[K28-Kre1p] was constructedsium efflux are affected. Any effects on Tok1p channels,
by replacing the 0.8 kb BamHI/BglII K28 preprotoxin fragment intherefore, are likely to be late secondary events and are
pPGK-M28-I with the BamHI/BglII 225kre1 fragment, creating anprobably not the physiologically relevant lethal mech-
in-frame fusion of the K28 preprotoxin N terminus to the Kre1panism.
C terminus. DNA sequence analysis of these constructs (data not
shown) showed the predicted wild-type sequences within the Kre1p
protein fragments and at the fusion junction.
Experimental Procedures
For recovery of the kre1.12 allele, the NheI to NsiI fragment of
YEp351[KRE1], including KRE1 and 446 5 flanking and 140 3 flank-
Yeast Strains, Culture Media, and Methods
ing residues, was subcloned back into YEp351. The product has
S. cerevisiae strain SEY6210 (MAT  leu2-3 his3-200 lys2-801 trp1-
unique EcoRV and SpeI sites within the KRE1 fragment and was
901 suc2-9) was provided by Dr. S. Emr (Robinson et al., 1988).
cut at these sites, excising most of the KRE1 reading frame, and
Its kre1::HIS3 derivative, in which the KRE1 reading frame is entirely
transformed into strain 95.8d. The plasmid recovered from Leu
replaced by the HIS3 gene, was provided by Dr. H. Bussey. Strains
transformants, containing the recovered kre1.12 allele, was unable
R95/8a, R95/8b, R95/8c, and R95/8d are tetrad segregants from a
to complement toxin resistance in strain 95.8d or a kre1 mutant
third backcross of the K1 resistant mutant R9 to sensitive strains
and was used for sequence analysis.
506 and 518 (Schmitt and Compain, 1995). Strain NYTOK1 (MAT
The T7-Kre1p fusion was constructed by amplifying KRE1 using
a ura3-52 trp1 his3-200 tok1::TRP1) and its isogenic TOK1 parent
YEp351[KRE1] as template and the 5 and 3 KRE1 primers (see
NY1489 were provided by Dr. S. Goldstein (Ahmed et al., 1999).
above) and cloning the product into pET24a() (Novagen) to give
Cells were grown in YEPD medium at 30C. Transformation was
pET24[KRE1]. pET24[KRE1] was transformed into E. coli BL21 (DE3),
carried out by the lithium acetate method according to Ito et al.
and expression of the T7-Kre1p-fusion (33.5 kDa) was induced by
(1983), and transformants were selected on appropriate synthetic
addition of IPTG according to the manufacturer’s instructions. In-
(YNB) media. Matings and sporulation were performed by standard
duced cells were washed twice with PBS (pH 7.0) and sonicated.
methods (Mortimer and Hawthorne, 1975). Diploid selection and
Cell debris was removed and expression of the fusion was assayed
ascus dissections were carried out using a micromanipulator (Singer
by SDS-PAGE and Western blot using a monoclonal mouse T7-
MSM system series 200). For spheroplast preparation, the appro-
antibody (Novagen). Samples of the sonication supernatant were
priate yeast strain was grown in YEPD medium to late exponential
also used in binding to the K1 toxin-pustulan columns.
phase (5  107 cells per ml), harvested, and washed twice with
sterile water. The washed cells were suspended in Tris/HCl-buffer
Toxin Binding to Intact Cells and Spheroplasts(0.1 M Tris-HCl [pH 8.0]; 5 mM DTT; 5 mM EDTA), incubated at 30C
and Glucan Assaysfor 30 min, and washed twice in 1.2 M sorbitol in the same buffer.
Binding of K1 toxin to intact yeast cells or spheroplasts was exam-Washed cells were then suspended in 1.2 M sorbitol containing 0.5
ined indirectly by estimating the amount of toxin remaining in solu-M NaPO4 (pH 6.8), and spheroplasts were generated by treatment
tion after incubating a given number of yeast cells in the presencewith Zymolyase-20T (Schmitt and Tipper, 1990).
of toxin for 10 min at 4C (Al-Aidroos and Bussey, 1978). ToxinK1 toxin was prepared as described by Pfeiffer and Radler (1982)
activity remaining in the supernatant was tested by the killing zoneusing S. cerevisiae strain T158C (MAT a his4C-864) as K1 toxin
assay, and bound toxin was calculated from the difference, as de-producer. In brief, strain T158C was grown at 20C in synthetic
scribed previously (Schmitt and Radler, 1988). Binding of K1 toxinB-medium. Stationary growth phase cell-free culture supernatant
to spheroplasts was determined in the same way, except that sphe-was concentrated 1,000-fold by ultrafiltration using a Sartorius ultra-
roplasts were incubated in 100 mM McIlvaine buffer (pH 4.7) con-filtration system (SM 16525) and trifluoracetate-membranes with a
taining 1.2 M sorbitol as osmotic stabilizer. -1,6 glucan contentmolecular cutoff of 10 kDa. These K1 toxin preparations were filter
was determined as described by Boone et al. (1990). Data are thesterilized and kept frozen at20C. Diploid strains are normally used
average of at least three determinations.as toxin source in killer assays to avoid the potentially confounding
growth-inhibitory effects of mating pheromones. Use of MAT a
strains as targets in critical assays of sensitivity described here Binding of T7-Kre1p to K1 Using
avoided this problem. In addition, ultrafiltration should have re- a Pustulan/Sepharose Column
moved a-factor from these preparations. They had no effect on MAT Pustulan (Roth, Germany) was coupled to epoxy-activated sepha-
 immune cells, demonstrating the absence of significant a-factor rose 6B (Amersham-Pharmacia) according to manufacturer’s in-
activity. Toxin activity was tested against S. cerevisiae LL20 (MAT structions. A 2 ml bed-volume column was equilibrated in 10 mM
 his3-11,15 leu2-3,112 can1 gal1) as sensitive lawn, as previously McIlvaine buffer (pH 4.7). Samples were loaded in the same buffer
described (Schmitt and Radler, 1987). Killer toxin activity is ex- and eluted with a linear gradient of up to 500 mM NaCl in the same
pressed in arbitrary units (Schmitt and Tipper, 1990); 104 units of buffer. Fractions of 1.5 ml were collected. To test for eluted toxin,
K1 toxin correspond to about 1 ng of pure toxin and give a growth fractions were dialyzed against 10 mM McIlvaine buffer (pH 4.7),
concentrated, and applied to MBA plates (pH 4.7) seeded with theinhibition zone of 16 mm on this strain.
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sensitive tester strain S. cerevisiae 192.2d (MAT a leu2 ura3). To (1981). Effect of yeast killer toxin on sensitive yeast cells of Saccha-
romyces cerevisiae. J. Biol. Chem. 256, 10420–10425.test for the eluted T7-Kre1p fusion, concentrated samples were
analyzed by a Western blot, as described above. Eisfeld, K., Riffer, F., Mentges, J., and Schmitt, M.J. (2000). Endocy-
totic uptake and retrograde transport of a virally encoded killer toxin
Western Immunoblot Analysis in yeast. Mol. Microbiol. 37, 926–940.
Yeast transformants were grown to late log phase in appropriate Gordon, V.M., Nelson, K.L., Buckley, J.T., Stevens, V.L., Tweten,
media for plasmid selection. Extracellular (secreted) yeast proteins R.K., Elwood, P.C., and Leppla, S.H. (1999). Clostridium septicum
were concentrated from cell-free culture supernatants by ethanol alpha toxin uses glycosylphosphatidylinositol-anchored protein re-
precipitation. Approximately 2  107 cells were harvested and me- ceptors. J. Biol. Chem. 274, 27274–27280.
chanically lysed by vortexing with glass beads. Cell debris and glass
Hamada, K., Fukuchi, S., Arisawa, M., Baba, M., and Kitada, K.beads were removed by low-speed centrifugation (1,000  g), and
(1998). Screening for glycosylphosphatidylinositol (GOI)-dependentthe resulting supernatant was analyzed by SDS-PAGE. Protein sam-
cell wall proteins in Saccharomyces cerevisiae. Mol. Gen. Genet.ples were separated in Tris-tricine sodium dodecyl sulfate polyacryl-
258, 53–59.amide gels according to the procedure described by Schagger and
Hamada, K., Terashima, H., Arisawa, M., Yabuki, N., and Kitada, K.von Jagow (1987). After electrotransfer to PVDF membranes, blots
(1999). Amino acid residues in the omega-minus region participate inwere incubated with a polyclonal antibody directed against the /-
cellular localization of yeast glycosylphosphatidylinositol-attachedfragment of K28 toxin (diluted 1/250), thereafter with an alkaline
proteins. J. Bacteriol. 181, 3886–3889.phosphatase-coupled anti-rabbit secondary antibody (Sigma, di-
luted 1/3,000), and finally developed in a NBT/BCIP solution (Roche). Hill, J.E., Myers, A.M., Koerner, T.J., and Tzagoloff, A. (1986). Yeast/
For analysis of subcellular localization of the in vivo expressed K28/ E. coli shuttle vectors with multiple unique restriction sites. Yeast
GFP/Kre1p fusion, yeast transformants were spheroplasted by 2, 163–167.
treatment with Zymolyase-20T, and the resulting supernatant was
Hutchins, K., and Bussey, H. (1983). Cell wall receptor for yeast
dialyzed over night against water and lyophilized. Spheroplasts were
killer toxin: involvement of (1→ 6)-beta-D-glucan. J. Bacteriol. 154,
disrupted with glass beads, cell debris and glass beads were re-
161–169.
moved by centrifugation at 1,000  g, and the resulting supernatant
Ito, H., Fukuda, Y., Murata, K., and Kimura, A. (1983). Transformationwas subjected to high-speed centrifugation at 13,000  g, resulting
of intact yeast cells treated with alkali cations. J. Bacteriol. 153,in a pellet highly enriched for cytoplasmic membranes. This pellet
163–168.was suspended in gel loading buffer and immediately used for SDS-
PAGE and Western analysis as described above. For immunochemi- Martinac, B., Zhu, H., Kubalski, A., Zhou, X.L., Culbertson, M., Bus-
cal signal detection, a monoclonal anti-GFP antibody was used sey, H., and Kung, C. (1990). Yeast K1 killer toxin forms ion channels
(Roche; diluted 1/1000), followed by treatment with a secondary in sensitive yeast spheroplasts and in artificial liposomes. Proc. Natl.
mouse anti-IgG antibody (Sigma) as described above. Acad. Sci. USA 87, 6228–6232.
Mortimer, R.K., and Hawthorne, D.C. (1975). Genetic mapping in
Immunfluorescence Microscopy yeast. Methods Cell Biol. 11, 221–233.
Exponentially growing yeast cells of strain SEY6210 [kre1] express-
Nelson, K.L., Raja, S.M., and Buckley, J.T. (1997). The glycosylphos-
ing either K28/GFP/Kre1p or K28/GFP were harvested and washed
phatidylinositol-anchored surface glycoprotein Thy-1 is a receptor
twice with PBS buffer (pH 7.4). Cells were resuspended in PBS and
for the channel-forming toxin aerolysin. J. Biol. Chem. 272, 12170–
immunfluorescence microscopy was performed using a confocal
12174.
laser scanning microscope (Bio-Rad MRC1024) under standard
Pfeiffer, P., and Radler, F. (1982). Purification and characterizationFITC-settings.
of extracellular and intracellular killer toxin of Saccharomyces cere-
visiae strain 28. J. Gen. Microbiol. 128, 2699–2706.Acknowledgments
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